NCT/Study#
NCT03919071 /
COG-ACNS1723
A Phase 2 Study Of Dabrafenib (NSC# 763760) With Trametinib (NSC# 763093) After Local Irradiation In Actively-Diagnosed BRAF V600-Mutant High-Grade Glioma (HGG)
DISEASE GROUP:
Pediatric Oncology
current phase:
Phase II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
